Not logged in : Login

About: Biocon     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent, within Data Space : ods-qa.openlinksw.com:8896 associated with source document(s)

Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space.

AttributesValues
type
dbpprop:founder
dbpprop:locationCountry
dbpprop:incomeYear
dbpprop:isin
  • INE376G01013
dbpprop:netIncomeYear
sameAs
wasDerivedFrom
dbpedia-owl:abstract
  • Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space. Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb(Itolizumab) and KRABEVA (Bevacizumab). Biocon and Syngene together employ about 9,200 personnel.
  • Biocon est une entreprise indienne de biotechnologie, basée à Bengalore. Elle est fondée par Kiran Mazumdar-Shaw. Elle est notamment spécialisée dans les enzymes, la fabrication d'insuline ou l'oncologie.
  • Biocon ist ein indisches, auf Krebs- und Diabetes-mellitus-Medikamente spezialisiertes Biotechnologieunternehmen mit Sitz in Bengaluru. Es steht gemessen am Umsatz auf dem 16. Platz weltweit und ist damit das größte Indiens. Zusätzlich expandiert die Firma mit der Gründung der Tochterfirmen (Molekulare Biotechnologie und Synthetische Chemie) und (Mikrobielle Fermentierung, Biodiversität, Bioprozessierung, Contract Research) in weitere Segmente. Das Unternehmen beschäftigt derzeit 2000 Mitarbeiter, von denen 10 % einen Doktor und 30 % einen Masterabschluss haben; 30 % sind Frauen und das Durchschnittsalter liegt bei 28 Jahren.
dbpedia-owl:thumbnail
dbpedia-owl:type
dbpedia-owl:wikiPageExternalLink
dbpedia-owl:wikiPageID
dbpedia-owl:wikiPageRevisionID
comment
  • Biocon ist ein indisches, auf Krebs- und Diabetes-mellitus-Medikamente spezialisiertes Biotechnologieunternehmen mit Sitz in Bengaluru. Es steht gemessen am Umsatz auf dem 16. Platz weltweit und ist damit das größte Indiens. Zusätzlich expandiert die Firma mit der Gründung der Tochterfirmen (Molekulare Biotechnologie und Synthetische Chemie) und (Mikrobielle Fermentierung, Biodiversität, Bioprozessierung, Contract Research) in weitere Segmente.
  • Biocon est une entreprise indienne de biotechnologie, basée à Bengalore. Elle est fondée par Kiran Mazumdar-Shaw. Elle est notamment spécialisée dans les enzymes, la fabrication d'insuline ou l'oncologie.
  • Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space.
label
  • Biocon
  • Biocon
  • Biocon
dbpprop:wikiPageUsesTemplate
dbpprop:revenueYear
name
  • Biocon Limited
dbpprop:numEmployees
topic
Faceted Search & Find service v1.17_git55 as of Mar 01 2021


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3322 as of Mar 14 2022, on Linux (x86_64-generic-linux-glibc25), Single-Server Edition (7 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2022 OpenLink Software